PharVision Advisers’s Gold.com Inc GOLD Stock Holding History

PharVision Advisers’s Portfolio GOLD Stock Details GOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-11,143	Closed	-$288K	–	687
2025 Q3	$288K	Buy	+11,143	New	+$264K	0.16%	250

Other funds holding GOLD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

PharVision Advisers's GOLD Position: Q4 2025 in Review

PharVision Advisers sold out of Gold.com Inc (GOLD) in Q4 2025, closing a stake of 11,143 shares — an estimated $288K sold.

PharVision Advisers first reported a position in GOLD in Q3 2025 and held it in 1 quarter. The position peaked at $288K in Q3 2025. 177 funds tracked by Wall St. Rank hold GOLD as of Q4 2025.

PharVision Advisers reported no remaining Gold.com Inc position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 11,143 Gold.com Inc shares in Q4 2025, an estimated $288K.
PharVision Advisers first reported a position in Gold.com Inc in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Gold.com Inc position peaked at $288K in Q3 2025.
177 funds tracked by Wall St. Rank held Gold.com Inc as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.